KELLY STRATEGIC CRISPR & GENE EDITING TECHNOLOGY ETF - USD Toevoegen aan een lijst
|
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 7,38 USD | -1,60% |
|
-2,45% | -25,75% |
Samenstelling van de Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
Toevoegen aan een lijst 0 geselecteerde |
Koers
|
Verschil (%)
|
Varia. 5d.
|
Vaira. 1 jan.
|
Gewicht
| |
|---|---|---|---|---|---|---|
| 568 USD | +0,93% | -2,75% | +7,01% | 11.69% | ||
| 21,38 USD | -3,26% | -13,93% | -29,88% | 11.15% | ||
| 53,74 USD | -0,59% | -2,72% | -14,15% | 8.55% | ||
| 23,81 USD | -1,16% | -2,10% | -12,53% | 8.03% | ||
| 2,88 USD | +1,05% | -3,03% | -49,74% | 6.97% | ||
| 2,99 USD | +3,10% | +0,67% | -11,01% | 4.87% | ||
| 5,2 USD | +0,58% | -7,64% | -48,67% | 4.83% | ||
| 161,2 USD | +3,15% | +2,66% | +4,05% | 4.81% | ||
| 6,48 USD | -0,31% | -6,43% | -26,86% | 4.71% | ||
| 5,19 USD | +0,97% | -1,70% | -62,77% | 4.13% | ||
| 93,17 CHF | +2,13% | +1,56% | +9,78% | 3.79% | ||
| 0,5644 USD | +3,52% | -5,17% | +3,88% | 3.66% | ||
| 2,5 USD | +1,63% | -0,79% | -22,12% | 3.54% | ||
| 130,4 USD | -0,77% | -13,44% | -6,20% | 2.57% | ||
| 41,12 USD | +2,17% | -0,28% | -19,85% | 2.37% | ||
| 4,22 USD | -3,21% | -6,43% | -1,17% | 2.23% | ||
| 89,76 EUR | +1,34% | +0,27% | -.--% | 2.20% | ||
| 104,3 USD | +3,20% | -2,07% | -25,11% | 1.77% | ||
| 455,3 USD | +2,77% | -0,35% | +11,91% | 1.71% | ||
| 980,2 USD | +1,06% | -0,49% | +11,60% | 1.62% | ||
| 224,9 USD | +2,21% | +3,27% | -13,07% | 0.65% | ||
Beschrijving
| ISIN-code | US48817R7061 |
|---|---|
| Totalekostenratio (TER) | 0.78% |
| Activaklassen | |
| Sector | |
| Grootte | |
| Valuta | |
| Beheerder | |
| Onderliggende waarde | Strategic CRISPR & Gene Editing Technology Index NR - USD |
Kenmerken
| Rechtsgebied | |
| Methode van replicatie | |
| Replicatiemodel | |
| Aanmaakdatum |
12-01-2022
|
| Dividendbeleid | |
| Geografisch zwaartepunt |
Veranderingen in de stand van zaken ( 31-10-2023 )
| Volume (EUR) | 2 M€ |
|---|---|
| Volume 1 maand | 2 M€ |
| AuM 3 months | 2 M€ |
| AuM 6 months | 2 M€ |
| AuM 12 months | 5 M€ |
- Beurs
- ETF
- Koers XDNA
- Samenstelling Kelly Strategic CRISPR & Gene Editing Technology ETF - USD